This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morgan, B. J. Articles by Victor, R. G. Search for Related Content PubMed PubMed Citation Articles by Morgan, B. J. Articles by Victor, R. G.

Hypertension, Vol 18, 458-466, Copyright © 1991 by American Heart Association

ARTICLES

Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats

BJ Morgan, T Lyson, U Scherrer and RG Victor
Department of Internal Medicine (Cardiology Division), University of Texas Southwestern Medical Center, Dallas 75235-9034.

Cyclosporine-induced immunosuppression has emerged as a new cause of hypertension, but the underlying mechanisms are poorly understood. In patients, this hypertension is accompanied by sympathetic neural activation. We therefore hypothesized that increased sympathetic nerve discharge is an important mechanism by which cyclosporine raises blood pressure. To test this hypothesis, we examined effects of acute administration of cyclosporine (5 mg/kg i.v.) or vehicle on renal and lumbar sympathetic nerve activity, renal and femoral blood flow velocity (pulsed Doppler flowmetry), and arterial pressure in chloralose-anesthetized rats. Vehicle had no effect on sympathetic nerve activity, whereas cyclosporine caused renal and lumbar sympathetic nerve activity to increase progressively over 60 minutes to levels that were 362 +/- 46% and 388 +/- 70%, respectively, of the baseline values (p less than 0.05). These increases in sympathetic nerve activity were accompanied by proportional increases in renal and femoral vascular resistance and sustained increases in mean arterial pressure (+19 +/- 3 mm Hg, p less than 0.05 versus baseline). The cyclosporine-induced increases in regional vascular resistance and arterial pressure were greatly attenuated, or abolished, by ganglionic blockade or by clonidine (central sympatholysis) but were unaffected by angiotensin converting enzyme inhibition. These findings demonstrate that in an anesthetized animal preparation, the vasoconstrictor and blood pressure-raising effects of cyclosporine are caused by sympathetic neural activation.

This article has been cited by other articles:

				J. Wang, Z.-R. Zhang, C.-F. Chou, Y.-Y. Liang, Y. Gu, and H.-P. Ma Cyclosporine stimulates the renal epithelial sodium channel by elevating cholesterol Am J Physiol Renal Physiol, February 1, 2009; 296(2): F284 - F290. [Abstract] [Full Text] [PDF]

				D. Ramzy, L. C. Tumiati, E. Tepperman, R. Sheshgiri, J. Jackman, M. Badiwala, and V. Rao Dual immunosuppression enhances vasomotor injury: Interactive effect between endothelin-1 and nitric oxide bioavailability. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 938 - 944. [Abstract] [Full Text] [PDF]

				H. Liu, W. Ye, G. Guan, Z. Dong, Z. Jia, and T. Yang Developmental regulation of calcineurin isoforms in the rodent kidney: association with COX-2 Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1898 - F1904. [Abstract] [Full Text] [PDF]

				H. A. Shaltout and A. A. Abdel-Rahman Cyclosporine Induces Progressive Attenuation of Baroreceptor Heart Rate Response and Cumulative Pressor Response in Conscious Unrestrained Rats J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 966 - 973. [Abstract] [Full Text] [PDF]

				W. Zhang Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy Cardiovasc Res, February 1, 2002; 53(2): 294 - 303. [Abstract] [Full Text] [PDF]

				G. LIGTENBERG, R. J. HENÉ, P. J. BLANKESTIJN, and H. A. KOOMANS Cardiovascular Risk Factors in Renal Transplant Patients: Cyclosporin A Versus Tacrolimus J. Am. Soc. Nephrol., February 1, 2001; 12(2): 368 - 373. [Abstract] [Full Text]

				W. Zhang, J.-L. Li, M. Hosaka, R. Janz, J. M. Shelton, G. M. Albright, J. A. Richardson, T. C. Südhof, and R. G. Victor Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings PNAS, July 30, 2000; (2000) 170160397. [Abstract] [Full Text]

				D. Lucini, R. V. Milani, H. O. Ventura, M. R. Mehra, F. Messerli, and M. Pagani Study of Arterial and Autonomic Effects of Cyclosporine in Humans Hypertension, June 1, 2000; 35(6): 1258 - 1263. [Abstract] [Full Text] [PDF]

				J. Galle, C. Lehmann-Bodem, U. Hubner, A. Heinloth, and C. Wanner CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O2- formation Nephrol. Dial. Transplant., March 1, 2000; 15(3): 339 - 346. [Abstract] [Full Text] [PDF]

				P. van de Borne, N. Montano, K. Narkiewicz, J. P. Degaute, R. Oren, M. Pagani, and V. K. Somers Sympathetic Rhythmicity in Cardiac Transplant Recipients Circulation, March 30, 1999; 99(12): 1606 - 1610. [Abstract] [Full Text] [PDF]

				H. J. Oskarsson, T. G. Hofmeyer, and M. T. Olivari Cyclosporine Impairs the Ability of Human Platelets to Mediate Vasodilation Hypertension, June 1, 1997; 29(6): 1314 - 1321. [Abstract] [Full Text]

				M. Ryuzaki, L. K. Stahl, T. Lyson, R. G. Victor, and V. S. Bishop Sympathoexcitatory Response to Cyclosporin A and Baroreflex Resetting Hypertension, February 1, 1997; 29(2): 576 - 582. [Abstract] [Full Text]

				M. Sander, P. G. Hansen, and R. G. Victor Sympathetically Mediated Hypertension Caused by Chronic Inhibition of Nitric Oxide Hypertension, October 1, 1995; 26(4): 691 - 695. [Abstract] [Full Text]

				W. Zhang, J.-L. Li, M. Hosaka, R. Janz, J. M. Shelton, G. M. Albright, J. A. Richardson, T. C. Sudhof, and R. G. Victor Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings PNAS, August 15, 2000; 97(17): 9765 - 9770. [Abstract] [Full Text] [PDF]